Synthesis of Antibacterial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies
How to cite: Ciocarlan, A.; Lungu, L.; Shova, S.; Vornicu, N.; Bolocan, N.; Kulcițki, V.; Aricu, A. Synthesis of Antibacterial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies. Preprints 2024, 2024110043. https://doi.org/10.20944/preprints202411.0043.v1 Ciocarlan, A.; Lungu, L.; Shova, S.; Vornicu, N.; Bolocan, N.; Kulcițki, V.; Aricu, A. Synthesis of Antibacterial Norlabdane Compounds with Rearranged Cycle B and Molecular Docking Studies. Preprints 2024, 2024110043. https://doi.org/10.20944/preprints202411.0043.v1
Abstract
The synthesis of tetra- and pentanorlabdane compounds with rearranged cycle B based on commercially available (+)-sclareolide is reported. Desired compounds were prepared from intermediate ketones via Baeyer-Villiger oxidation. The structures of synthesized compounds were confirmed by spectral IR, 1D (1H, 13C and 15N, DEPT) and 2D (H-COSY, H,C-HSQC, H,C-HMBC, H,N-HMBC, NOESY) NMR analyses, mass-spectrometry and single crystal X-rays diffraction. Two of the four obtained compounds showed high antifungal and antimicrobial activity, comparable and exceeding that of standards Caspofungin and Kanamycin. DFT calculations revealed the stability of compounds in gas, DCM, water and methanol. Molecular docking to four targets (1KZN, 1U1Z, 3QLS, 2Q85) showed good agreement with the results of in vitro evaluation and confirmed the biological activity of compounds 3 and 4, with binding affinities comparable and for some targets exceeding that of Caspofungin and Kanamycin.
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)